Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
Atzpodien J, Kirchner H, Rebmann U, Soder M, Gertenbach U, Siebels M, Roigas J, Raschke R, Salm S, Schwindl B, Müller SC, Hauser S, Leiber C, Huland E, Heinzer H, Siemer S, Metzner B, Heynemann H, Fornara P, Reitz M. Atzpodien J, et al. Among authors: siebels m. Br J Cancer. 2006 Aug 21;95(4):463-9. doi: 10.1038/sj.bjc.6603271. Epub 2006 Aug 8. Br J Cancer. 2006. PMID: 16909131 Free PMC article. Clinical Trial.
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
Atzpodien J, Kirchner H, Jonas U, Bergmann L, Schott H, Heynemann H, Fornara P, Loening SA, Roigas J, Müller SC, Bodenstein H, Pomer S, Metzner B, Rebmann U, Oberneder R, Siebels M, Wandert T, Puchberger T, Reitz M; Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). Atzpodien J, et al. Among authors: siebels m. J Clin Oncol. 2004 Apr 1;22(7):1188-94. doi: 10.1200/JCO.2004.06.155. Epub 2004 Feb 23. J Clin Oncol. 2004. PMID: 14981107 Clinical Trial.
[Impact of immunotherapy in metastatic kidney cancer in Germany after introduction of new target therapy--results of a telephone survey of the German Society of Immuno- and Targeted Therapy (DGFIT)].
Siebels M, Staehler M, Hegele A, Varga Z, Oberneder R, Doehn C, Heinzer H; Deutsche Gesellschaft für Immun- und Targeted Therapie e.V. (DGFIT). Siebels M, et al. Aktuelle Urol. 2010 Mar;41(2):122-30. doi: 10.1055/s-0029-1224676. Epub 2009 Nov 20. Aktuelle Urol. 2010. PMID: 19937556 German.
Treatment algorithm for metastatic renal cell carcinoma--recommendations based on evidence and clinical practice.
Bergmann L, Beck J, Bothe K, Brinkmann OA, Buse S, Goebell PJ, Grünwald V, Holzapfel K, Kübler H, Marschner NW, Mickisch G, Schultze-Seemann W, Siebels M, Siemer S, Störkel S, Gschwend JE. Bergmann L, et al. Among authors: siebels m. Oncol Res Treat. 2014;37(3):136-41. doi: 10.1159/000360179. Epub 2014 Feb 21. Oncol Res Treat. 2014. PMID: 24685918 Free article.
Immunotherapy in metastatic renal cell carcinoma.
Rohrmann K, Staehler M, Haseke N, Bachmann A, Stief CG, Siebels M. Rohrmann K, et al. Among authors: siebels m. World J Urol. 2005 Jul;23(3):196-201. doi: 10.1007/s00345-004-0470-4. Epub 2005 Apr 2. World J Urol. 2005. PMID: 15806434 Review.
67 results